Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study
暂无分享,去创建一个
M. Nieminen | S. Oparil | U. de Faire | R. Devereux | K. Borch-Johnsen | S. Kjeldsen | S. Julius | M. Olsen | H. Ibsen | B. Dahlöf | C. Mogensen | L. Lindholm | K. Wachtell | P. Omvik | F. Fyhrquist | O. Lederballe‐Pedersen | Ying Wan | Y. Wan | B. Dahlöf
[1] M. Nieminen,et al. Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy , 2004, Journal of hypertension.
[2] B. Brenner,et al. Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy , 2004, Circulation.
[3] Zhongxin Zhang,et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. , 2004, Kidney international.
[4] M. Nieminen,et al. Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study , 2003, Annals of Internal Medicine.
[5] L. Sechi,et al. Regression of microalbuminuria in type 1 diabetes. , 2003, The New England journal of medicine.
[6] N. Wareham,et al. Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy , 2003, Diabetic medicine : a journal of the British Diabetic Association.
[7] Hans L Hillege,et al. Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population , 2002, Circulation.
[8] M. Nieminen,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[9] M. Nieminen,et al. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study , 2002, Journal of hypertension.
[10] B. Williams,et al. Microalbuminuria in essential hypertension: redefining the threshold. , 2002, Journal of hypertension.
[11] Jackson T. Wright,et al. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. , 2002, American heart journal.
[12] A. Stenehjem,et al. Left ventricular mass assessed by electrocardiography and albumin excretion rate as a continuum in untreated essential hypertension , 2001, Journal of hypertension.
[13] K. Borch-Johnsen,et al. Elevated Urinary Albumin Excretion Is Associated With Impaired Arterial Dilatory Capacity in Clinically Healthy Subjects , 2001, Circulation.
[14] M. Schroll,et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. , 2000, Hypertension.
[15] G. Navis,et al. Renoprotective therapy: titration against urinary protein excretion , 1999, The Lancet.
[16] L. Bouter,et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[17] F. Locatelli,et al. Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .
[18] F. Locatelli,et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. , 1996, The New England journal of medicine.
[19] K. Borch-Johnsen,et al. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. , 1995, Clinical science.
[20] B. Feldt-Rasmussen,et al. Comparison of Overnight, Morning and 24‐Hour Urine Collections in the Assessment of Diabetic Microalbuminuria , 1987, Diabetic medicine : a journal of the British Diabetic Association.